icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of MK-5172 Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection: Final Results of the C-SPIRIT Study
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Edward Gane,1 Ziv Ben Ari,2 Lindsay Mollison,3 Eli Zuckerman,4 Rafael Bruck,5 Yaacov Baruch,6 Anita Howe,7 Janice Wahl,7 Sanhita Bhanja,7 Peggy Hwang,7 Yue Zhao,7 Michael N. Robertson7
1Auckland Clinical Studies, Grafton, Auckland, New Zealand; 2Liver Disease Center, Sheba Medical Center, Ramat Gan, Israel; 3Fremantle Hepatitis Services, Fremantle Hospital, Fremantle, Australia; 4Liver Unit, Carmel Medical Center Technion Faculty of Medicine, Haifa, Israel; 5Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 6Liver Unit, Rambam Health Care Campus, Haifa, Israel; 7Merck and Co., Inc. Whitehouse Station, NJ, USA EASL:
 

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif